Generate Biomedicines ($GENB) Insider Trading & Smart Money Activity

Generate Biomedicines, Inc. · Biotechnology · Latest filing Oct 16, 2026

Generate Biomedicines, Inc. ($GENB) has 3 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 3
Analyst ratings on file: 0

GENB insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	2 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	1 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All GENB insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
Oct 16, 2026	13F	Banque Pictet & Cie	New	+1.77M sh	$26.63M			Read
May 15, 2026	13F	Baker Bros. Advisors	New	+1.42M sh	$24.02M	-9.2%	-15.1%	Read
May 15, 2026	13F	Baker Bros. Advisors	New	+1.42M sh	$18.17M	-9.2%	-15.1%	—

1W / 1M / 6M = how GENB moved from the trade or filing date.

Institutions moving GENB (13F)

Frequently asked questions

Which institutions changed their GENB positions?

Recent 13F filers moving the stock include Baker Bros. Advisors and Banque Pictet & Cie.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text